Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis.

Binwu HuHuiqian FanXiao LvSongfeng ChenZeng-Wu Shao

Published in: Cancer cell international (2018)

In conclusion, our meta-analysis suggested that elevated CXCL5 expression might be an adverse prognostic marker for cancer patients, which could help the clinical decision making process.

Keyphrases

poor prognosis
systematic review
decision making
binding protein
long non coding rna
randomized controlled trial